Efficacy of intranasal corticosteroids for the ocular symptoms of allergic rhinitis: A systematic review

Allergy and Asthma Proceedings

Volumn 32, Issue 1, 2011, Pages 22-35

  Hong, Jison ^a   Bielory, Brett ^b   Rosenberg, J Loren ^b   Bielory, Leonard ^b  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; ALPHA 2 ANTIPLASMIN; ANDROGEN; ANTITHROMBIN III; BLOOD CLOTTING FACTOR 12; BRADYKININ; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C1S INHIBITOR; ESTROGEN; HIGH MOLECULAR WEIGHT KININOGEN; PREKALLIKREIN; SERINE PROTEINASE; TISSUE PLASMINOGEN ACTIVATOR;

ABDOMINAL CRAMP; ABDOMINAL PAIN; ALLERGIC RHINITIS; ALPHA 1 ANTITRYPSIN DEFICIENCY; ANGIONEUROTIC EDEMA; ARTHRALGIA; CLINICAL ASSESSMENT; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; ESTROGEN THERAPY; FACE RASH; FATIGUE; GENE MUTATION; GENETIC DISORDER; HUMAN; LABORATORY DIAGNOSIS; LARYNX EDEMA; MYALGIA; NAUSEA AND VOMITING; PARESTHESIA; PATHOPHYSIOLOGY; REVIEW;

ADMINISTRATION, INTRANASAL; ADRENAL CORTEX HORMONES; ANTI-ALLERGIC AGENTS; CONJUNCTIVITIS, ALLERGIC; HUMANS; RHINITIS, ALLERGIC, PERENNIAL; TREATMENT OUTCOME;

EID: 79251612655     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2011.32.3420     Document Type: Review

References (47)

1. Gregory C, Cifaldi M, and Tanner LA. Targeted intervention programs: Creating a customized practice model to improve the treatment of allergic rhinitis in a managed care population. Am J Manag Care 5:485-496, 1999. (Pubitemid 29202927)
2. Lehman JM, and Blaiss MS. Selecting the optimal oral antihistamine for patients with allergic rhinitis. Drugs 66:2309-2319, 2006.
3. Sibbald B, and Rink E. Labelling of rhinitis and hayfever by doctors. Thorax 46:378-381, 1991.
4. Takano Y, Narita S, Kobayashi K, et al. Seasonal allergic conjunctivitis in Hakodate. Nippon Ganka Gakkai Zasshi 108:606-611, 2004.
5. Wuthrich B, Brignoli R, Canevascini M, and Gerber M. Epidemiological survey in hay fever patients: Symptom prevalence and severity and influence on patient management. Schweiz Med Wochenschr 128:139-143, 1998. (Pubitemid 28052760)
6. Allergies in America. A landmark survey of nasal allergy sufferers: Executive summary. Available online at www. myallergiesinamerica.com/; last accessed August 28, 2007.
7. Pitt AD, Smith AF, Lindsell L, et al. Economic and quality-of-life impact of seasonal allergic conjunctivitis in Oxfordshire. Ophthalmic Epidemiol 11:17-33, 2004. (Pubitemid 38367076)
8. Simons FE. Advances in H1-antihistamines. N Engl J Med 351:2203-2217, 2004.
9. Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and Its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 63(suppl 86):8-160, 2008.
10. DeWester J, Philpot EE, Westlund RE, et al. The efficacy of intranasal fluticasone propionate in the relief of ocular symptoms associated with seasonal allergic rhinitis. Allergy Asthma Proc 24:331-337, 2003. (Pubitemid 37414434)
11. Bernstein DI, Levy AL, Hampel FC, et al. Treatment with intranasal fluticasone propionate significantly improves ocular symptoms in patients with seasonal allergic rhinitis. Clin Exp Allergy 34:952-957, 2004. (Pubitemid 38824075)
12. Weiner JM, Abramson MJ, and Puy RM. Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: Systematic review of randomised controlled trials. BMJ (Clin Res Ed) 317:1624-1629, 1998.
13. Yanez A, and Rodrigo GJ. Intranasal corticosteroids versus topical H1 receptor antagonists for the treatment of allergic rhinitis: A systematic review with meta-analysis. Ann Allergy Asthma Immunol 89:479-484, 2002. (Pubitemid 36187991)
14. Price D, Bond C, Bouchard J, et al. International Primary Care Respiratory Group (IPCRG) Guidelines: Management of allergic rhinitis. Prim Care Respir J 15:58-70, 2006.
15. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Controlled Clin Trials 17:1-12, 1996.
16. Naclerio R. Intranasal corticosteroids reduce ocular symptoms associated with allergic rhinitis. Otolaryngol Head Neck Surg 138:129-139, 2008. (Pubitemid 351172486)
17. Naclerio RM, Pinto J, deTineo M, and Baroody FM. Elucidating the mechanism underlying the ocular symptoms associated with allergic rhinitis. Allergy Asthma Proc 29:24-28, 2008.
18. Bielory L. Ocular symptom reduction in patients with seasonal allergic rhinitis treated with the intranasal corticosteroid mometasone furoate. Ann Allergy Asthma Immunol 100:272-279, 2008. (Pubitemid 351398007)
19. Schenkel E. Oral antihistamines have proven efficacy in treating ocular symptoms of allergic rhinitis. J Allergy Clin Immunol 120:1473-147, 2007;
20. Kaiser HB, Naclerio RM, Given J, et al. Fluticasone furoate nasal spray: A single treatment option for the symptoms of seasonal allergic rhinitis. J Allergy Clin Immunol 119:1430-1437, 2007. (Pubitemid 46855849)
21. Martin BG, Ratner PH, Hampel FC, et al. Optimal dose selection of fluticasone furoate nasal spray for the treatment of seasonal allergic rhinitis in adults and adolescents. Allergy Asthma Proc 28:216-225, 2007.
22. Nolik R, Pearlman D, Teper A, and Gates D. Mometasone furoate improves nasal and ocular symptoms of seasonal allergic rhinitis in adolescents. Allergy Asthma Proc 30:406-412, 2009.
23. Andrews CP, Martin BG, Jacobs RL, et al. Fluticasone furoate nasal spray is more effective than fexofenadine for nighttime symptoms of seasonal allergy. Allergy Asthma Proc 30:128-138, 2009.
24. Baroody FM, Shenaq D, DeTineo M, et al. Fluticasone furoate nasal spray reduces the nasal - ocular reflex: A mechanism for the efficacy of topical steroids in controlling allergic eye symptoms. J Allergy Clin Immunol 123:1342-1348, 2009.
25. Jacobs R, Martin B, Hampel F, et al. Effectiveness of fluticasone furoate 110 microg once daily in the treatment of nasal and ocular symptoms of seasonal allergic rhinitis in adults and adolescents sensitized to mountain cedar pollen. Curr Med Res Opin 25:1393-1401, 2009.
26. Kaliner MA, Storms W, Tilles S, et al. Comparison of olopatadine 0.6% nasal spray versus fluticasone propionate 50 microg in the treatment of seasonal allergic rhinitis. Allergy Asthma Proc 30:255-262, 2009.
27. Weinstein S, Qaqundah P, Georges G, and Nayak A. Efficacy and safety of triamcinolone acetonide aqueous nasal spray in children aged 2 to 5 years with perennial allergic rhinitis: A randomized, double-blind, placebo-controlled study with an open-label extension. Ann Allergy Asthma Immunol 102:339-347, 2009.
28. Can D, Tanac R, Demir E, et al. Is the usage of intranasal glucocorticosteroids alone in allergic rhinitis sufficient? Allergy Asthma Proc 27:248-253, 2006.
29. Saengpanich S, deTineo M, Naclerio RM, and Baroody FM. Fluticasone nasal spray and the combination of loratadine and montelukast in seasonal allergic rhinitis. Arch Otolaryngol Head Neck Surg 129:557-562, 2003.
30. Hughes K, Glass C, Ripchinski M, et al. Efficacy of the topical nasal steroid budesonide on improving sleep and daytime somnolence in patients with perennial allergic rhinitis. Allergy 58: 380-385, 2003. (Pubitemid 36605725)
31. Ciprandi G, Canonica WG, Grosclaude M, et al. Effects of budesonide and fluticasone propionate in a placebo-controlled study on symptoms and quality of life in seasonal allergic rhinitis. Allergy 57:586-591, 2002.
32. Kaszuba SM, Baroody FM, deTineo M, et al. Superiority of an intranasal corticosteroid compared with an oral antihistamine in the as-needed treatment of seasonal allergic rhinitis. Arch Intern Med 161:2581-2587, 2001.
33. Berlin JM, Golden SJ, Teets S, et al. Efficacy of a steroid nasal spray compared with an antihistamine nasal spray in the treatment of perennial allergic rhinitis. J Am Osteopath Assoc 100: S8-S13, 2000.
34. Condemi J, Schulz R, and Lim J. Triamcinolone acetonide aqueous nasal spray versus loratadine in seasonal allergic rhinitis: Efficacy and quality of life. Ann Allergy Asthma Immunol 84:533-538, 2000. (Pubitemid 30365417)
35. Wilson A, Dempsey OJ, Sims EJ, et al. Evaluation of treatment response in patients with seasonal allergic rhinitis using domiciliary nasal peak inspiratory flow. Clin Exp Allergy 30:833-838, 2000.
36. Ortolani C, Foresi A, Di Lorenzo G, et al. A double-blind, placebo-controlled comparison of treatment with fluticasone propionate and levocabastine in patients with seasonal allergic rhinitis. FLNCO2 Italian Study Group. Allergy 54:1173-1180, 1999.
37. Dolovich J, Wong AG, Chodirker WB, et al. Multicenter trial of fluticasone propionate aqueous nasal spray in ragweed allergic rhinitis. Ann Allergy 73:147-153, 1994.
38. al-Mohaimeid H. A parallel-group comparison of budesonide and beclomethasone dipropionate for the treatment of perennial allergic rhinitis in adults. J Int Med Res 21:67-73, 1993.
39. Beswick KB, Kenyon GS, and Cherry JR. A comparative study of beclomethasone dipropionate aqueous nasal spray with terfenadine tablets in seasonal allergic rhinitis. Curr Med Res Opin 9:560-567, 1985.
40. Hill D, Connelly D, and Vorath J. Beclomethasone dipropionate aerosol in the treatment of children with severe perennial rhinitis. Med J Aust 2:603-604, 1978. (Pubitemid 9177846)
41. Spangler, D.L., et al. Randomized, double-masked comparison of olopatadine ophthalmic solution, mometasone furoate monohydrate nasal spray, and fexofenadine hydrochloride tablets using the conjunctival and nasal allergen challenge models. Clin Ther 25:2245-2267, 2003.
42. Giger, R., et al. Comparison of once- versus twice-daily use of beclomethasone dipropionate aqueous nasal spray in the treatment of allergic and non-allergic chronic rhinosinusitis. Eur Arch Otorhinolaryngol 260:135-140, 2003.
43. Lanier, B.Q., et al. Comparison of the efficacy of combined fluticasone propionate and olopatadine versus combined fluticasone propionate and fexofenadine for the treatment of allergic rhinoconjunctivitis induced by conjunctival allergen challenge. Clin Ther 24:1161-1174, 2002.
44. Boner, A., et al. The efficacy and tolerability of fluticasone propionate aqueous nasal spray in children with seasonal allergic rhinitis. Allergy 50:498-505, 1995.
45. Spector, S., et al. Multicenter, double-blind, placebo-controlled trial of triamcinolone acetonide nasal aerosol in the treatment of perennial allergic rhinitis. Ann Allergy 64:300-305, 1990.
46. Kobayashi R.H., et al. Beclomethasone dipropionate aqueous nasal spray for seasonal allergic rhinitis in children. Ann Allergy 62:205-208, 1989. (Pubitemid 19093211)
47. Welsh, P.W., et al. Efficacy of beclomethasone nasal solution, flunisolide, and cromolyn in relieving symptoms of ragweed allergy. Mayo Clin Proc 62:125-134, 1987.